Accelerated adverse cardiac remodeling in a model of TET2 mutation-driven clonal hematopoiesis is ameliorated by IFNa treatment by modulating the monocyte response

20 June 2025 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Understanding the interplay between cancer and cardiovascular disease Research and New Technology CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

ESC 365 is supported by

ESC 365 is supported by